| Model Number |
SR-0830-CS |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Numbness (2415); Ischemia Stroke (4418); Thrombosis/Thrombus (4440)
|
| Date of Event |
05/05/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that the patient experienced stent thrombosis and stroke post procedure.An enroute transcarotid stent was selected for use in a left side transcarotid artery revascularization (tcar) procedure.During the procedure, plaque prolapse was noted within the stent and a second stent was placed to reline the vessel.The procedure was completed with no notable issues.Six days post procedure, the patient returned with right side numbness.The patient was admitted and administrated with heparin drip.Imaging performed revealed stent thrombosis and an embolic stroke.There was no p2y12 test performed but the patient was switched from plavix to brilinta and eliquis.Additionally, it was reported that the patient had an intraluminal filling defect noted prior to the tcar procedure.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient experienced stent thrombosis and stroke post procedure.An enroute transcarotid stent was selected for use in a left side transcarotid artery revascularization (tcar) procedure.During the procedure, plaque prolapse was noted within the stent and a second stent was placed to reline the vessel.The procedure was completed with no notable issues.Six days post procedure, the patient returned with right side numbness.The patient was admitted and administrated with heparin drip.Imaging performed revealed stent thrombosis and an embolic stroke.There was no p2y12 test performed but the patient was switched from plavix to brilinta and eliquis.Additionally, it was reported that the patient had an intraluminal filling defect noted prior to the tcar procedure.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation results:
device history record (dhr) review:
it was confirmed this device met manufacturing specification prior to distribution and there were no manufacturing deviations which could have contributed to the reported event.Labeling review:
review of the instructions for use (ifu) confirmed there was relevant content and sufficient guidance with respect to the circumstances described within this complaint.No updates are required to the ifu as a result of this event.Risk review:
a review of the enroute transcarotid stent device confirmed that the reported events are known events defined in the product's risk management documentation.These event types has been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion:
based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of no problem detected.
|
| |
|
Search Alerts/Recalls
|